BPG is committed to discovery and dissemination of knowledge
Articles in Press
3/31/2026 8:51:32 AM | Browse: 14 | Download: 0
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Correspondence |
| Article Title |
Letter to the Editor: Steatotic liver disease in chronic hepatitis C - a marker of systemic risk, not direct-acting antiviral treatment failure
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Abdo Imad El Tawil and Claudia Alexandra Pontes Ivantes |
| Funding Agency and Grant Number |
|
| Corresponding Author |
Abdo Imad El Tawil, Principal Investigator, Researcher, Department of Medical Research, Faculdade Evangélica Mackenzie do Paraná, Rua Padre Anchieta 2770, Curitiba 80730-000, Paraná, Brazil. abdoieltawil@gmail.com |
| Key Words |
Chronic hepatitis C; Direct-acting antiviral; Genotype 3; Liver cirrhosis; Steatotic liver disease; Liver fibrosis; Metabolic disfunction |
| Core Tip |
This letter discusses the real-world findings of Janczura et al, who evaluated the impact of steatotic liver disease on chronic hepatitis C virus infection in the era of direct-acting antivirals. Their work highlights how metabolic dysfunction, aging, and genotype-specific characteristics contribute to persistent liver risk despite viral cure. By emphasizing the role of noninvasive steatosis assessment in identifying high-risk patients and guiding long-term monitoring, this correspondence reinforces the clinical relevance of steatotic liver disease in shaping the prognosis and follow-up strategies for individuals with current or past hepatitis C virus infection. |
| Citation |
El Tawil AI, Ivantes CAP. Letter to the Editor: Steatotic liver disease in chronic hepatitis C - a marker of systemic risk, not direct-acting antiviral treatment failure. World J Hepatol 2026; In press |
 |
Received |
|
2025-12-08 06:11 |
 |
Peer-Review Started |
|
2025-12-08 10:06 |
 |
First Decision by Editorial Office Director |
|
2026-02-06 10:20 |
 |
Return for Revision |
|
2026-02-06 10:20 |
 |
Revised |
|
2026-02-08 21:35 |
 |
Publication Fee Transferred |
|
|
 |
Second Decision by Editor |
|
2026-03-31 02:35 |
 |
Second Decision by Editor-in-Chief |
|
|
 |
Final Decision by Editorial Office Director |
|
2026-03-31 08:51 |
 |
Articles in Press |
|
2026-03-31 08:51 |
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
|
| ISSN |
1948-5182 (online) |
| Open Access |
This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc. |
| Copyright |
©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc. |
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
© 1993-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345